-
Neurocrine Biosciences, Inc. is an
American biopharmaceutical company founded in 1992. It is
headquartered in San Diego, California, and led by CEO Kevin...
-
Neurocrine can
refer to: A type of cell
signaling similar to paracrine, but
involving neurons. See
chemical synapse for more details.
Neurocrine Biosciences...
-
antipsychotic drug for
schizophrenia that was out-licensed
Nexera Pharma in to
Neurocrine Biosciences, a
United States-based
pharmaceutical company. It is administered...
- "NBI-98854 – VMAT2
Inhibitor | Tics in
Children Treatment |
Neurocrine Biosciences". www.
neurocrine.com.
Archived from the
original on 30
January 2015. Retrieved...
-
biotechnology companies.
Major biotechnology companies like
Illumina and
Neurocrine Biosciences are
headquartered in San Diego,
while many
other biotech and...
- Bial sold
exclusive marketing rights for the
United States and
Canada to
Neurocrine Biosciences for an
initial payment of US$30 million.
Opicapone was authorised...
-
Chemical synapses are
biological junctions through which neurons'
signals can be sent to each
other and to non-neuronal
cells such as
those in muscles...
-
priority review designations. The FDA
granted the
approval of
Crenessity to
Neurocrine Biosciences, Inc.
Crinecerfont was
approved for
medical use in the United...
- 1948), a scientist,
entrepreneur and
venture capitalist, is the
chair of
Neurocrine Biosciences, of Fate Therapeutics, and of Daré Bioscience, Inc. in San...
-
Administration (FDA) (Press release). 1
October 2024.
Retrieved 16
December 2024. "
Neurocrine Biosciences Announces FDA
Approval of
Crenessity (crinecerfont), a First-in-class...
